Sökning: onr:"swepub:oai:lup.lub.lu.se:654ec271-fd40-4397-b8d6-54528c648f80" >
Effect of Everolimu...
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients
-
- Arora, Satish (författare)
- University of Oslo,Oslo university hospital
-
- Andreassen, Arne K. (författare)
- Oslo university hospital
-
- Karason, Kristjan (författare)
- Sahlgrenska University Hospital
-
visa fler...
-
- Gustafsson, Finn (författare)
- Copenhagen University Hospital
-
- Eiskjær, Hans (författare)
- Aarhus University Hospital
-
- Bøtker, Hans Erik (författare)
- Aarhus University Hospital
-
- Rådegran, Göran (författare)
- Lund University,Lunds universitet,Hjärt-lungsjukdom - information, stöd och bemötande,Forskargrupper vid Lunds universitet,Cardiopulmonary disease - information, support and reception,Lund University Research Groups,Skåne University Hospital
-
- Gude, Einar (författare)
- Oslo university hospital
-
- Ioanes, Dan (författare)
- Sahlgrenska University Hospital
-
- Solbu, Dag (författare)
- Novartis Norge AS
-
- Dellgren, Göran (författare)
- Sahlgrenska University Hospital
-
- Ueland, Thor (författare)
- Oslo university hospital,UiT The Arctic University of Norway, Tromsø,University of Oslo
-
- Aukrust, Pål (författare)
- UiT The Arctic University of Norway, Tromsø,Oslo university hospital,University of Oslo
-
- Gullestad, Lars (författare)
- Oslo university hospital,University of Oslo
-
visa färre...
-
(creator_code:org_t)
-
- 2018
- 2018
- Engelska.
-
Ingår i: Circulation. Heart failure. - 1941-3297. ; 11:9, s. 004050-004050
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background Cardiac allograft vasculopathy (CAV) limits survival after heart transplantation, and the effect of different immunosuppressive regimens on CAV is not fully understood. The randomized SCHEDULE trial (Scandinavian Heart Transplant Everolimus De Novo Study With Early Calcineurin Inhibitors Avoidance) evaluated whether initiation of the proliferation signal inhibitor everolimus and early cyclosporine elimination can reduce CAV development. Methods and Results The SCHEDULE trial was a multicenter Scandinavian trial, where 115 de novo heart transplantation recipients were randomized to everolimus with complete cyclosporine withdrawal 7 to 11 weeks after heart transplantation or standard cyclosporine-based immunosuppression. Seventy-six (66%) patients had matched intravascular ultrasound examinations at baseline and 12 and 36 months. Intravascular ultrasound analysis evaluated maximal intimal thickness, percent atheroma volume, and total atheroma volume. Qualitative plaque analysis using virtual histology assessed fibrous, fibrofatty, and calcified tissue as well as necrotic core. Serum inflammatory markers were measured in parallel. The everolimus group (n=37) demonstrated significantly reduced CAV progression as compared with the cyclosporine group (n=39) at 36 months (Δ maximal intimal thickness, 0.09±0.05 versus 0.15±0.16 mm [ P=0.03]; Δ percent atheroma volume, 5.3±2.8% versus 7.6±5.9% [ P=0.03]; and Δ total atheroma volume, 33.9±71.2 versus 54.2±96.0 mm3 [ P=0.34], respectively]. At 36 months the number of everolimus patients with rejection graded ≥2R was 15 (41%) as compared with 5 (13%) in the cyclosporine group ( P=0.01). Everolimus did not affect CAV morphology or immune marker activity during the follow-up period. Conclusions The SCHEDULE trial demonstrates that everolimus initiation and early cyclosporine elimination significantly reduces CAV progression at 12 months, and this beneficial effect is clearly sustained at 36 months. Clinical trial registration URL: https://www.clinicaltrials.gov . Unique identifier: NCT01266148.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- allograft
- calcineurin inhibitors
- cyclosporine
- everolimus
- heart transplantation
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Arora, Satish
-
Andreassen, Arne ...
-
Karason, Kristja ...
-
Gustafsson, Finn
-
Eiskjær, Hans
-
Bøtker, Hans Eri ...
-
visa fler...
-
Rådegran, Göran
-
Gude, Einar
-
Ioanes, Dan
-
Solbu, Dag
-
Dellgren, Göran
-
Ueland, Thor
-
Aukrust, Pål
-
Gullestad, Lars
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
Circulation. Hea ...
- Av lärosätet
-
Lunds universitet